Integrated Filing — IndAS
General information about company
| Scrip Code |
532531 |
| NSE Symbol |
STAR |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE939A01011 |
| Name of company |
STRIDES PHARMA SCIENCE LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
18-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
11-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Single segment |
| Description of single segment |
Pharmaceutical |
| Start date and time of board meeting |
18-05-2026 12:30:00 |
| End date and time of board meeting |
18-05-2026 14:15:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
1,32,347.00 |
4,85,868.30 |
|
Other income |
812.80 |
15,071.30 |
|
Total income |
1,33,159.80 |
5,00,939.60 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
40,887.60 |
1,55,891.90 |
| (b) |
Purchases of stock-in-trade |
12,744.60 |
36,153.60 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(7.70) |
3,827.50 |
| (d) |
Employee benefit expense |
24,711.40 |
92,895.70 |
| (e) |
Finance costs |
4,157.90 |
17,854.50 |
| (f) |
Depreciation, depletion and amortisation expense
|
5,324.90 |
20,240.10 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
30,040.40 |
1,04,570.30 |
|
Total other expenses |
30,040.40 |
1,04,570.30 |
|
Total expenses |
1,17,859.10 |
4,31,433.60 |
| 3 |
Total profit before exceptional items and tax |
15,300.70 |
69,506.00 |
| 4 |
Exceptional items |
(640.50) |
(2,684.30) |
| 5 |
Total profit before tax |
14,660.20 |
66,821.70 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
1,661.10 |
7,787.60 |
| 8 |
Deferred tax |
215.90 |
1,629.00 |
| 9 |
Total tax expenses |
1,877.00 |
9,416.60 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
12,783.20 |
57,405.10 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
144.90 |
46.90 |
| 16 |
Total profit (loss) for period |
12,928.10 |
57,452.00 |
| 17 |
Other comprehensive income net of taxes |
1,970.40 |
4,402.30 |
| 18 |
Total Comprehensive Income for the period |
14,898.50 |
61,854.30 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
12,694.40 |
55,619.30 |
|
Total profit or loss, attributable to non-controlling interests |
233.70 |
1,832.70 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
14,645.40 |
59,770.20 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
253.10 |
2,084.10 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
9,217.30 |
9,217.30 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
3,01,539.20 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
13.77 |
60.34 |
|
Diluted earnings (loss) per share from continuing operations |
13.77 |
60.34 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
13.77 |
60.34 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
13.77 |
60.34 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
99,243.00 |
|
Capital work-in-progress |
16,112.30 |
|
Investment property |
24.30 |
|
Goodwill |
59,442.40 |
|
Other intangible assets |
51,349.50 |
|
Intangible assets under development |
28,615.80 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
1,247.40 |
|
Non-current financial assets |
|
|
Non-current investments |
27,888.20 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
0.00 |
|
Other non-current financial assets |
|
| 1 |
Other non-current financial assets |
10,906.00 |
| 2 |
Deferred tax assets (net) |
28,386.20 |
| 3 |
Other non-current assets |
8,174.20 |
|
Total of other non-current financial assets |
47,466.40 |
|
Total non-current financial assets |
75,354.60 |
|
Deferred tax assets (net) |
|
|
Other non-current assets |
|
|
Total of other non-current assets |
|
|
Total non-current assets |
3,31,389.30 |
| 2 |
Current assets |
|
|
Inventories |
1,63,479.40 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
1,28,896.40 |
|
Cash and cash equivalents |
18,869.60 |
|
Bank balance other than cash and cash equivalents |
2,444.60 |
|
Loans, current |
813.60 |
|
Other current financial assets |
|
|
Total of other current financial assets |
46,775.70 |
|
Total current financial assets |
1,97,799.90 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
|
|
Total of other current assets |
|
|
Total current assets |
3,61,279.30 |
| 3 |
Non-current assets classified as held for sale |
54.60 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
6,92,723.20 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
9,217.30 |
|
Other equity |
3,01,539.20 |
|
Total equity attributable to owners of parent |
3,10,756.50 |
|
Non controlling interest |
4,177.20 |
|
Total equity |
3,14,933.70 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
55,231.60 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Other non-current financial liabilities |
8,305.30 |
|
Total of other non-current financial liabilities |
8,305.30 |
|
Total non-current financial liabilities |
63,536.90 |
|
Provisions, non-current |
12,636.40 |
|
Deferred tax liabilities (net) |
12,066.90 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
|
|
Total of other non-current liabilities |
|
|
Total non-current liabilities |
88,240.20 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
1,11,637.40 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
4,640.10 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
1,26,327.90 |
|
Total Trade payable |
1,30,968.00 |
|
Other current financial liabilities |
|
| 1 |
Other current financial liabilities |
24,973.20 |
|
Total of other current financial liabilities |
24,973.20 |
|
Total current financial liabilities |
2,67,578.60 |
|
Other current liabilities |
7,495.30 |
| 1 |
Other current liabilities |
7,495.30 |
|
Total of other current liabilities |
7,495.30 |
|
Provisions, current |
9,635.90 |
|
Current tax liabilities (Net) |
4,839.50 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
2,89,549.30 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
3,77,789.50 |
|
Total equity and liabilites |
6,92,723.20 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Items that will not be reclassified to statement of profit and loss |
(5,747.10) |
(4,670.10) |
|
Total Amount of items that will not be reclassified to profit and loss |
(5,747.10) |
(4,670.10) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(1,181.40) |
(911.20) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Items that may be reclassified to statement of profit and loss |
6,064.00 |
6,153.10 |
|
Total Amount of items that will be reclassified to profit and loss |
6,064.00 |
6,153.10 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
(472.10) |
(2,008.10) |
| 5 |
Total Other comprehensive income |
1,970.40 |
4,402.30 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
66,821.70 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
17,854.50 |
|
Adjustments for decrease (increase) in inventories |
(28,452.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
(10,932.40) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
0.00 |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
31,072.30 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
0.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
20,240.10 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
(283.90) |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(4,083.40) |
|
Adjustments for dividend income |
4,048.10 |
|
Adjustments for interest income |
0.00 |
|
Adjustments for share-based payments |
31.40 |
|
Adjustments for fair value losses (gains) |
0.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
(126.90) |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
(10,730.20) |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
10,541.40 |
|
Net cash flows from (used in)
operations |
77,363.10 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
7,111.20 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
70,251.90 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
11,926.00 |
|
Purchase of property, plant and equipment |
42,293.50 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
9,216.70 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
457.70 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
3,389.50 |
|
Net cash flows from (used in)
investing activities |
(17,303.60) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
38.60 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
17,050.00 |
|
Repayments of borrowings |
38,278.80 |
|
Payments of lease liabilities |
3,671.10 |
|
Dividends paid |
3,686.50 |
|
Interest paid |
16,793.10 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(45,340.90) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
7,607.40 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
5.80 |
|
Net increase (decrease) in cash
and cash equivalents |
7,613.20 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
11,256.40 |
|
Cash and cash equivalents cash
flow statement at end of period |
18,869.60 |